TEST:

Labcorp Plasma Detect ID MRD

Labcorp Plasma Detect ID MRD defines a personalized, tumor-informed MRD signature by analyzing whole exome sequencing (WES) of tumor DNA and matched germline DNA collected at the baseline timepoint. Based on this analysis, a patient’s tumor specific panel of 18–50 variants is developed to detect ctDNA in blood samples, both at the baseline and monitoring timepoints.